Device Trial Radar · NCT02533531
Proof of Concept Study for 1 Lead Patch Technology
Last checked: Nov 20, 2026Latest source record: Apr 6, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1
Actual
Start
Apr 16, 2014
Primary completion
Jun 9, 2016
Study completion Jun 9, 2016
Sponsor
- Lead sponsor
- LifeWatch Services, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 26, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is intended to assess the feasibility and usability of the 1 Lead Patch as a whole, on patients outside the hospital, in the out-patient setting.
Conditions
- Telemetry
Interventions
1-Lead PatchDevice
The 1-Lead Patch will record and transmit ECG data to a gateway, which will then transmit the data to a central database.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite Outcome Measure - 100% Successful ECG AcquisitionTime frame: Between 7 and 14 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Mt. Sinai Medical Center
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.